Your shopping cart is currently empty

PROTACG9a/GLP degrader 1 is a G9a/GLP PROTAC degrader with a DC50 of 336 nM for G9a and 988 nM for GLP. It exhibits inhibitory activity against G9a with an IC50 of 98 nM. This compound effectively inhibits the migration of breast cancer MCF-7 cells without affecting their proliferation and is utilized in breast cancer research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PROTACG9a/GLP degrader 1 is a G9a/GLP PROTAC degrader with a DC50 of 336 nM for G9a and 988 nM for GLP. It exhibits inhibitory activity against G9a with an IC50 of 98 nM. This compound effectively inhibits the migration of breast cancer MCF-7 cells without affecting their proliferation and is utilized in breast cancer research. |
| Targets&IC50 | G9a:336 nM (DC50) |
| In vitro | PROTAC G9a/GLP degrader 1 (Compound 4) demonstrates potent and sustained degradation ability for G9a/GLP at concentrations of 0.03-10 μM over 0-72 hours and effectively reduces the levels of the G9a catalytic product H3K9me2 in breast cancer MCF-7 cells. At concentrations of 0.1-10 μM for 24-72 hours, it significantly inhibits the migration ability of MCF-7 cells without notably affecting their viability. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.